Piper Jaffray Cuts Price Target on Nuvectra Corporation (NVTR) Following 2Q Revenue Beat

August 11, 2016 8:19 AM EDT
Get Alerts NVTR Hot Sheet
Price: $5.57 -1.42%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade NVTR Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Piper Jaffray maintained a Neutral rating on Nuvectra Corporation (NASDAQ: NVTR), and cut the price target to $10.00 (from $12.00), following the company's 2Q earnings report. NVTR reported revenue of $2.6M, compared with $2.4M estimates.

Analyst Brooks West commented, "Nuvectra reported 2Q16 revenue of $2.6M vs. our $2.4M as stronger revenues related to NVTR’s partnership with Aleva Neurotherapeutics and volume of component sales from its NeuroNexus subsidiary offset a slower ramp in Algovita SCS ramp versus our model. Management stated that it is focused on the build out of its SCS field force with 28 current active territories and ~10 territories scheduled to complete training by the end of August. This leaves the company on track to have ~50 active territories by the end of 3Q16. That said, we have taken a more conservative approach to our first year Algovita ramp assumptions given the lag in navigating hospital and ASC purchasing departments cited by management along with the natural 3-month progression of patients from identification to permanent implant. We reiterate our N rating, lowering PT to $10 from $12."

For an analyst ratings summary and ratings history on Nuvectra Corporation click here. For more ratings news on Nuvectra Corporation click here.

Shares of Nuvectra Corporation closed at $6.64 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Piper Jaffray, Earnings, Brooks West

Add Your Comment